Analysis of chromosomal genes and proteins of gyrA and gyrB from Indonesian Local-Strain Salmonella enterica serovar Typhi
Abstract
INTRODUCTION
Typhoid fever is an infection of the gastrointestinal tract caused by Salmonella Typhi. Ciprofloxacin is the most widely used second-line therapy; it provides good results in therapy. Indonesia has a unique resistance pattern of fluoroquinolones. Earlier studies of the gyrA and gyrB from local S. Typhi strains showed no mutation, and amino acid replacement was identified in all reported codons. In this study, we explored the whole sequence of the gyrA and gyrB further to understand the association of the unique characteristics of our local strains with fluoroquinolone resistance.
METHODOLOGY
This was an analytical study with a cross-sectional approach. Isolates collection, identification, antibiotic sensitivity test, DNA extraction, gene amplification, purification, and sequencing were carried out. Bioedit was used for the analysis of sequencing data.
RESULTS
Four isolates were identified as S. Typhi. Three isolates were sensitive to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin. One isolate was intermediate to nalidixic acid, ciprofloxacin, levofloxacin, and resistant to moxifloxacin. The gyrA and gyrB genes were aligned with S. Typhi Ty2 reference sequence (NCBI GenBank AE014613.1). Three amino acid changes (Gly133Glu, Asn538Asp, and Thr856Ala) and one amino acid change (Ala416Ser) were found in gyrA and gyrB, respectively. Protein secondary structures of these isolates showed some changes in alpha helices, beta sheets, random coils, and beta…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.